| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
European Healthcare Acquisition & Growth Company B.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €8.85 |
| 52 Week High | €10.30 |
| 52 Week Low | €8.85 |
| Beta | -0.079 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| QX0 | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 2.0% |
| 1Y | n/a | 25.3% | 5.9% |
Return vs Industry: Insufficient data to determine how QX0 performed against the German Capital Markets industry.
Return vs Market: Insufficient data to determine how QX0 performed against the German Market.
Price Volatility
| QX0 volatility | |
|---|---|
| QX0 Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: QX0 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine QX0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Cornelius Baur | www.ehc-company.com |
European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe.
European Healthcare Acquisition & Growth Company B.V. Fundamentals Summary
| QX0 fundamental statistics | |
|---|---|
| Market cap | €183.00m |
| Earnings (TTM) | €26.48m |
| Revenue (TTM) | n/a |
6.9x
P/E Ratio0.0x
P/S RatioIs QX0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QX0 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | -€26.48m |
| Earnings | €26.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.32 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did QX0 perform over the long term?
See historical performance and comparison